UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement
Sales, net	$ 10,829	$ 10,490	$ 21,088	$ 20,791
Cost of goods sold	3,936	4,238	7,660	8,316
Gross profit	6,893	6,252	13,428	12,475
Operating expense:
Selling, general and administrative	1,740	1,818	3,432	3,619
Research & development	119	119	238	229
Total operating expense	1,859	1,937	3,670	3,848
Operating income	5,034	4,315	9,758	8,627
Other income (expense)	23	64	49	165
Income before provision for income taxes	5,057	4,379	9,807	8,792
Provision for income taxes	1,187	1,120	2,402	2,316
Net income	$ 3,870	$ 3,259	$ 7,405	$ 6,476
Earnings per common share (basic)	$ 1.04	$ 0.87	$ 1.99	$ 1.72
Earnings per common share (diluted)	$ 1.04	$ 0.86	$ 1.98	$ 1.72
Shares outstanding (basic)	3,716	3,758	3,715	3,756
Shares outstanding (diluted)	3,732	3,776	3,732	3,773
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 1,675	$ (3,016)	$ 2,331	$ (3,426)
Unrealized gain (loss) on investments net of taxes of $3, $0, $3 and ($4)	5	0	5	(6)
Total comprehensive income	$ 5,550	$ 243	$ 9,741	$ 3,044